Catalent’s biotherapeutics business provides advanced technologies and comprehensive solutions for biologic, biosimilar, mRNA, and vaccine development, manufacturing, and supply. With technology platforms including GPEx® cell line engineering and SMARTag® bioconjugation, combined with process development, biomanufacturing, fill/finish, device assembly, and analytical services, Catalent is the partner for clinical and commercial success.